Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 1,480 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Commercially Available Clear all

Conditions: Immune Thrombocytopenia
Interventions: Eltrombopag, Steroids, IVIG, Rho(D) Immune Globulin; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Year to 18 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 27
States / cities: Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 22 more

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Ulcer Foot
Interventions: Human Autologous Homologous Skin Construct, Additional Outer Dressing Applicaiton, Offloading, Fibracol Wound Dressing; Other
Lead sponsor: PolarityTE; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Martinsville, Virginia

Conditions: Alzheimer Disease, Dementia, Caregiver Burden, Quality of Life, Activities of Daily Living
Interventions: The MapHabit system, Dementia educational videos; Device
Lead sponsor: MapHabit, Inc.; Industry
Eligibility: Not listed
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pulmonary Hypertension
Interventions: Bardoxolone methyl; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 46
States / cities: Phoenix, Arizona • Beverly Hills, California • La Jolla, California + 32 more

Conditions: Uterine Fibroids, Heavy Menstrual Bleeding
Interventions: Elagolix, Placebo for Estradiol/Norethindrone Acetate, Estradiol/Norethindrone Acetate, Placebo for Elagolix; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 51 Years · Female only
Enrollment: 378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 103
States / cities: Birmingham, Alabama • Dothan, Alabama • Fairhope, Alabama + 89 more

Conditions: Disability Physical, Brain Injuries, Stroke, Spinal Cord Injuries, Multiple Sclerosis, Paralysis
Interventions: Using adaptive device.; Device
Lead sponsor: Madonna Rehabilitation Hospital; Other
Eligibility: 1 Year to 85 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Obesity
Interventions: Smartphone + Text Messaging with Health Coach; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 17 Years to 25 Years
Enrollment: 256 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Breast Cancer
Interventions: Mini rTG OMEGA-3 Fish Oil; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Mitral Regurgitation, Mitral Valve Insufficiency
Interventions: SAPIEN M3 valve and dock; Device
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 786 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2031
U.S. locations: 44
States / cities: Huntsville, Alabama • Phoenix, Arizona • La Jolla, California + 36 more

Conditions: Pectus Excavatum, Pain, Postoperative
Interventions: Use of PCA, Use of ESB for postoperative pain control after MIRPE, Use of INC for postoperative pain control after MIRPE; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 21 Years
Enrollment: 158 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Healthy
Interventions: Not listed
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Long-Term Memory Decline, Mild Cognitive Impairment
Interventions: LabyrinthVR, Placebo Games, Coherence, Tablet; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 62 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Oral Health
Interventions: PerioPull™; Dietary Supplement
Lead sponsor: Designs for Health; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Ellicott City, Maryland

Conditions: Sleep Restriction
Interventions: Additional protein and multi-nutrient beverage, Placebo beverage; Other
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 18 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Natick, Massachusetts

Conditions: Osteoporosis
Interventions: teriparatide; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 18
States / cities: Huntsville, Alabama • Montgomery, Alabama • Peoria, Arizona + 15 more

Conditions: Peripheral Vascular Disease, Peripheral Arterial Disease
Interventions: Evero DCB, Paclitaxel DCB; Combination Product
Lead sponsor: Cook Research Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 15
States / cities: Long Beach, California • New Haven, Connecticut • Washington D.C., District of Columbia + 12 more

Conditions: Type1diabetes, Type1 Diabetes Mellitus
Interventions: VSL#3; Dietary Supplement
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 5 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Depression
Interventions: BioKefir, Non-fermented milk; Dietary Supplement
Lead sponsor: Rush University Medical Center; Other
Eligibility: 21 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pain, Intractable, Pain, Chronic
Interventions: Commercially available neurostimulation systems; Device
Lead sponsor: MedtronicNeuro; Industry
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 10
States / cities: Carlsbad, California • Fort Myers, Florida • Edina, Minnesota + 7 more

Conditions: Schizophrenia
Interventions: Neuroadaptive cognitive training, Computer games; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 12 Years to 35 Years
Enrollment: 143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Leukemia
Interventions: Quizartinib, Placebo, Chemotherapy; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 52
States / cities: Goodyear, Arizona • Phoenix, Arizona • Tucson, Arizona + 43 more

Conditions: Alveolar Bone Loss
Interventions: INFUSE® Bone Graft; Device
Lead sponsor: Medtronic Spinal and Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 8
States / cities: Los Angeles, California • Greenwood Village, Colorado • Sarasota, Florida + 4 more

Conditions: Bipolar Disorder, Substance Use Disorder
Interventions: Icariin; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Systemic Amyloidosis
Interventions: 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m., 99mTc-Pyrophosphate; Drug
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Knoxville, Tennessee

Search by objective public record fields.

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

SkinTE™ in the Treatment of Diabetic Foot Wounds

Assistive Technology and Reduced Caregiver Burden

Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)

Impact of Custom Assistive and Adaptive Technology in Rehabilitation

Improving Cardiovascular Risk Factors in Black Young Adults

Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors

The ENCIRCLE Trial

Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum

Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software

Wayfinding Intervention in High-Fidelity Long-Term Memory

A Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental Health

Nutrition Intervention to Promote Immune Recovery From Sleep Restriction

Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

EVERO Drug-coated Balloon (DCB) Randomized Trial

Modulation of Type 1 Diabetes Susceptibility Through the Use of Probiotics

Fermented Milk Product With Probiotic and Its Impact on Mood of Patients With Treatment Resistant Depression

Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

Localized Alveolar Ridge Augmentation With Space Maintenance Devices

Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis